日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study

CHRONICLE 研究中,重度哮喘且肺功能正常的患者在生物制剂治疗后的结局

Panettieri, Reynold A Jr; Mohan, Arjun; Lugogo, Njira L; Ledford, Dennis K; Carstens, Donna D; Ambrose, Christopher S

Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review

生物制剂治疗重度哮喘患者减少阻塞性黏液栓的有效性:系统评价

Aegerter, Helena; Brightling, Christopher E; Dunican, Eleanor M; Lambrecht, Bart N; Lugogo, Njira L; Newell, John D Jr; Porsbjerg, Celeste; Svenningsen, Sarah; Clarke, Deborah; Lindsley, Andrew W; Nordenmark, Lars; Ambrose, Christopher S; Castro, Mario

Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect

CompEx哮喘的临床意义及其对疾病进程的影响:贝那利珠单抗的疗效

Bolton, Clare; Akuthota, Praveen; Lugogo, Njira; Barker, Peter; Bengtsson, Thomas; Peterson, Stefan; Siddiqui, Salman; Da Silva, Carla A

Evaluating Asthma Clinical Remission with Inhaled Therapy: Post Hoc Analyses of CAPTAIN

评估吸入疗法对哮喘临床缓解的影响:CAPTAIN 研究的事后分析

Oppenheimer, John; Pavord, Ian D; Corbridge, Tom; Crawford, Jodie; Gould, Steven; Hamouda, Mohamed; Howarth, Peter; Burrows, Emmeline; Moore, Alison; Noorduyn, Stephen G; Slade, David; Weng, Stephen; Lugogo, Njira

Disease Burden of Asthma Patients Utilizing Short-Acting Beta-2 Agonist-Only Inhalers as Rescue in the United States

美国使用短效β2受体激动剂吸入器作为急救药物的哮喘患者的疾病负担

Lugogo, Njira; Moon, Rena C; Chung, Yen; David, Joy; Motawakel, Omar; Rosenthal, Ning A; Skolnik, Neil

Asthma biologic effectiveness by age and sex in the US CHRONICLE study

美国 CHRONICLE 研究中按年龄和性别划分的哮喘生物制剂疗效

Baptist, Alan P; Soong, Weily; Chipps, Bradley E; Lugogo, Njira; Trevor, Jennifer; Carstens, Donna D; Pelletier, Marianne; Ambrose, Christopher S

Normal FEV(1) without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis

哮喘试验中正常FEV1无可逆性:安慰剂患者水平荟萃分析

Couillard, Simon; Mailhot-Larouche, Samuel; Meulmeester, Fleur L; Brusselle, Guy; Lachapelle, Philippe; Beasley, Richard W; Sont, Jacob K; Steyerberg, Ewout W; Pavord, Ian D; Lugogo, Njira

Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE Trial

Dupilumab 对中重度哮喘患者黏液负荷的影响:VESTIGE 试验

Porsbjerg, Celeste; Dunican, Eleanor M; Lugogo, Njira L; Castro, Mario; Papi, Alberto; Backer, Vibeke; Brightling, Christopher E; Bourdin, Arnaud; Virchow, J Christian; Zhang, Mei; Soler, Xavier; Rowe, Paul J; Deniz, Yamo; de Prado Gómez, Lucía; Sacks, Harry J; Jacob-Nara, Juby A

The Rapidly Evolving Landscape of Asthma Therapies Is Exhilarating, Yet a Lack of Innovation in Clinical Trial Design Makes Feasibility a Real Concern

哮喘治疗领域的快速发展令人振奋,但临床试验设计缺乏创新使得可行性成为一个真正的问题。

Lugogo, Njira

Leptin augments IL-13-induced airway eotaxins and submucosal eosinophilia in obesity-associated asthma.

瘦素可增强 IL-13 诱导的气道嗜酸性粒细胞和粘膜下嗜酸性粒细胞增多症,从而引起肥胖相关性哮喘

Ingram Jennifer L, McQuade Victoria L, Weiss Jasmine, Womble Jack T, Ihrie Mark D, Zhao Karen, Francisco Dave, Theriot Barbara, May Katelynn, Kim Haein, McCravy Matthew, Sauler Maor, Lugogo Njira L, Sunday Mary E, Everitt Jeffrey, Walker Julia K L, Tighe Robert M, Kraft Monica, Que Loretta G